Researchers report developing a drug that prolongs lifespan in some animals by about 25%, describing the work as a potential major biomedical breakthrough. The findings are presented as evidence that targeting biological aging pathways can produce meaningful increases in longevity.
Both outlets emphasize the possibility that the approach could translate to humans, but they do not claim that human lifespan has been extended. The reporting frames the results as an early step and highlights the next phase as determining whether similar effects can occur in people. The sources rely on the same core claim—an animal lifespan increase and optimism about future application—while providing limited detail about the specific species, study design, or mechanism of action.
